Related references
Note: Only part of the references are listed.The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU
M. Maurer et al.
ALLERGY (2017)
Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria
D. Stull et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
Zuo-Tao Zhao et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
Jonathan Graham et al.
PHARMACOECONOMICS (2016)
WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT AMONG CHRONIC SPONTANEOUS/IDIOPATHIC URTICARIA PATIENTS: RESULTSFROM THE FIRST INTERNATIONAL BURDEN OF ILLNESS STUDY (ASSURE-CSU)
M. Balp et al.
VALUE IN HEALTH (2015)
HEALTHCARE RESOURCE UTILISATION AMONG CHRONIC SPONTANEOUS/IDIOPATHIC URTICARIA PATIENTS-FINDINGS FROM THE FIRST INTERNATIONAL BURDEN OF ILLNESS STUDY (ASSURE-CSU)
H. Tian et al.
VALUE IN HEALTH (2015)
ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
Karsten Weller et al.
CLINICAL AND TRANSLATIONAL ALLERGY (2015)
The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update
T. Zuberbier et al.
ALLERGY (2014)
Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
Allen Kaplan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
Marcus Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Treatment of Chronic Spontaneous Urticaria
Allen P. Kaplan
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2012)
Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report
M. Maurer et al.
ALLERGY (2011)
Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report
Michael Drummond et al.
VALUE IN HEALTH (2009)
How to assess disease activity in patients with chronic urticaria?
A. Mlynek et al.
ALLERGY (2008)
The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies
L. M. Lamers et al.
HEALTH ECONOMICS (2006)
Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients
E Toubi et al.
ALLERGY (2004)
An overview of chronic urticaria
VS Beltrani
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2002)
Share Paper
